SDAIA Partners for 4th Riyadh Global Medical Biotechnology Summit

The Saudi Data and Artificial Intelligence Authority (SDAIA) is participating as a national partner in the fourth edition of the Riyadh Global Medical Biotechnology Summit (RGMBS 2026), taking place from September 14 to 16 under the patronage of His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince and Prime Minister. The summit, organized by the Ministry of National Guard Health Affairs, represented by the King Abdullah International Medical Research Center (KAIMRC), in partnership with the Ministry of Investment and SDAIA, convenes leading international scientists, healthcare leaders, and investors to explore advances across the life sciences sector.

Context and Background

The Riyadh Global Medical Biotechnology Summit has emerged as a premier platform for advancing biotechnology in the Kingdom and beyond. This fourth edition builds on previous successes, reflecting Saudi Arabia’s commitment to fostering innovation in healthcare and life sciences. The event aligns with the National Biotechnology Strategy, which aims to position the Kingdom as a global leader in biotechnology by 2030, leveraging data and artificial intelligence to drive breakthroughs in drug discovery, precision medicine, and personalized healthcare.

SDAIA’s role as a national partner underscores the critical importance of data infrastructure and AI in accelerating biotechnological research. By integrating advanced data governance frameworks and AI capabilities, SDAIA is enabling a new era of scientific discovery that can address pressing health challenges and improve patient outcomes worldwide.

Key Details

During the summit, SDAIA will showcase its scientific contributions, including an opening address by Alrebdi bin Fahad Alrebdi, Director of the National Data Management Office, on biotech data ecosystems. A dedicated workshop on national biotechnology data governance will further explore how robust data management can fuel innovation. Additionally, SDAIA will roll out the Biotech Data Regulatory Sandbox initiative in collaboration with KAIMRC, and sign a supplementary memorandum of understanding with the Ministry of National Guard. The authority’s pavilion will feature national technical enablers, data governance frameworks, and core services from the Tawakkalna app, demonstrating how digital tools support the National Biotechnology Strategy and Saudi Vision 2030.

Implications and Impact

SDAIA’s participation signals Saudi Arabia’s growing leadership in the global biotechnology landscape. By harnessing AI and data, the Kingdom is poised to accelerate drug discovery, enhance precision medicine, and attract international investment. The Biotech Data Regulatory Sandbox, a pioneering initiative, will provide a controlled environment for testing innovative data-driven solutions, ensuring regulatory compliance while fostering experimentation. This approach not only benefits Saudi Arabia but also contributes valuable insights to the global biotech community, reinforcing the Kingdom’s role as a hub for cutting-edge research and development.

Vision 2030 Alignment

This initiative directly supports Saudi Vision 2030 by advancing the National Biotechnology Strategy, which seeks to diversify the economy, create high-skilled jobs, and improve healthcare outcomes. SDAIA’s efforts in data governance and AI integration exemplify the Kingdom’s commitment to building a knowledge-based economy and achieving global leadership in technology and innovation. As Saudi Arabia continues to invest in biotechnology and AI, it reinforces its position as a forward-looking nation dedicated to the well-being of its people and the world.

20 Questions

Q1. What is the Riyadh Global Medical Biotechnology Summit?

A1. The Riyadh Global Medical Biotechnology Summit (RGMBS) is an annual event that brings together international scientists, healthcare leaders, and investors to explore advances in biotechnology and life sciences.

Q2. Who is organizing the fourth edition of RGMBS?

A2. The summit is organized by the Ministry of National Guard Health Affairs, represented by the King Abdullah International Medical Research Center (KAIMRC), in partnership with the Ministry of Investment and SDAIA.

Q3. What is SDAIA’s role in the summit?

A3. SDAIA is participating as a national partner, showcasing how data infrastructure and AI can accelerate biotechnology research, drug discovery, and precision medicine.

Q4. When and where is RGMBS 2026 taking place?

A4. RGMBS 2026 is being held in Riyadh from September 14 to 16, under the patronage of His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince and Prime Minister.

Q5. What is the Biotech Data Regulatory Sandbox initiative?

A5. It is a collaborative initiative between SDAIA and KAIMRC that provides a controlled environment for testing data-driven biotech solutions while ensuring regulatory compliance.

Q6. Who will deliver the opening address on biotech data ecosystems?

A6. Alrebdi bin Fahad Alrebdi, Director of the National Data Management Office at SDAIA, will deliver the opening address.

Q7. What memorandum of understanding will be signed during the summit?

A7. SDAIA will sign a supplementary memorandum of understanding with the Ministry of National Guard to further collaboration in biotechnology and data governance.

Q8. How does SDAIA’s participation support the National Biotechnology Strategy?

A8. By demonstrating AI and data infrastructure capabilities, SDAIA supports the strategy’s goals of advancing research, innovation, and healthcare outcomes in the Kingdom.

Q9. What is the Tawakkalna app’s role in this context?

A9. The Tawakkalna app serves as a core digital service showcasing how national technical enablers support the goals of the National Biotechnology Strategy and Vision 2030.

Q10. What are the key themes of RGMBS 2026?

A10. The summit focuses on advances in life sciences, including biotechnology research, drug discovery, precision medicine, and data governance.

Q11. Who are the expected participants at the summit?

A11. Leading international scientists, healthcare leaders, investors, and representatives from government entities and research institutions are participating.

Q12. How does the summit align with Saudi Vision 2030?

A12. It supports Vision 2030 by fostering innovation, economic diversification, and global leadership in biotechnology and AI, contributing to a knowledge-based economy.

Q13. What is the significance of the Biotech Data Regulatory Sandbox?

A13. It enables safe experimentation with data-driven biotech solutions, promoting innovation while maintaining regulatory oversight and ethical standards.

Q14. What can attendees expect at SDAIA’s pavilion?

A14. The pavilion will showcase national technical enablers, data governance frameworks, and core services from the Tawakkalna app, highlighting SDAIA’s role in advancing biotechnology.

Q15. How does SDAIA’s work impact precision medicine?

A15. By leveraging AI and data, SDAIA helps accelerate research and enable personalized treatments, improving patient outcomes and advancing precision medicine.

Q16. What is the role of the Ministry of Investment in the summit?

A16. The Ministry of Investment partners in organizing the summit to attract investment and foster collaborations that drive growth in the biotechnology sector.

Q17. What is KAIMRC’s contribution to the summit?

A17. KAIMRC, under the Ministry of National Guard Health Affairs, co-organizes the summit and collaborates with SDAIA on initiatives like the Biotech Data Regulatory Sandbox.

Q18. How does the summit promote international collaboration?

A18. By bringing together global experts and investors, the summit facilitates knowledge exchange, partnerships, and joint ventures in biotechnology and healthcare.

Q19. What are the expected outcomes of RGMBS 2026?

A19. The summit aims to forge new partnerships, advance research collaborations, and showcase Saudi Arabia’s leadership in biotechnology and AI-driven healthcare solutions.

Q20. How can international participants engage with SDAIA during the summit?

A20. International participants can visit SDAIA’s pavilion, attend workshops, and network with representatives to explore collaboration opportunities in data governance and biotechnology.

---